These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33036542)

  • 41. Pathway Activity Profiling (PAPi): from the metabolite profile to the metabolic pathway activity.
    Aggio RB; Ruggiero K; Villas-Bôas SG
    Bioinformatics; 2010 Dec; 26(23):2969-76. PubMed ID: 20929912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods.
    Dong H; Zhang A; Sun H; Wang H; Lu X; Wang M; Ni B; Wang X
    Mol Biosyst; 2012 Apr; 8(4):1206-21. PubMed ID: 22282765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomics combined with pattern recognition and bioinformatics analysis methods for the development of pharmacodynamic biomarkers on liver fibrosis.
    Fang J; Wang L; Wang Y; Qiu M; Zhang Y
    Mol Biosyst; 2017 Jul; 13(8):1575-1583. PubMed ID: 28671700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-throughput metabolomics investigates anti-osteoporosis activity of oleanolic acid via regulating metabolic networks using ultra-performance liquid chromatography coupled with mass spectrometry.
    Xu Y; Chen S; Yu T; Qiao J; Sun G
    Phytomedicine; 2018 Dec; 51():68-76. PubMed ID: 30466629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolomics and its application to the evaluation of the efficacy and toxicity of traditional Chinese herb medicines.
    Shi J; Cao B; Wang XW; Aa JY; Duan JA; Zhu XX; Wang GJ; Liu CX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():204-216. PubMed ID: 26657802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolomics workflow for lung cancer: Discovery of biomarkers.
    Tang Y; Li Z; Lazar L; Fang Z; Tang C; Zhao J
    Clin Chim Acta; 2019 Aug; 495():436-445. PubMed ID: 31103622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
    Xu EY; Schaefer WH; Xu Q
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nano-sized TiO
    Zhang Z; Liang ZC; Zhang JH; Tian SL; Le Qu J; Tang JN; De Liu S
    Ecotoxicol Environ Saf; 2018 Jun; 154():108-117. PubMed ID: 29454986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphological, proteomic and metabolomic insight into the effect of cerium dioxide nanoparticles to Phaseolus vulgaris L. under soil or foliar application.
    Salehi H; Chehregani A; Lucini L; Majd A; Gholami M
    Sci Total Environ; 2018 Mar; 616-617():1540-1551. PubMed ID: 29066204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
    Rodrigues D; Jerónimo C; Henrique R; Belo L; de Lourdes Bastos M; de Pinho PG; Carvalho M
    Int J Cancer; 2016 Jul; 139(2):256-68. PubMed ID: 26804544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic mechanism of Reduning injection in a rat model.
    Gao X; Huang C; Geng T; Chen X; Wang J; Liu J; Duan K; Cao L; Wang Z; Xiao W
    J Ethnopharmacol; 2020 Mar; 250():112429. PubMed ID: 31812644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Symposium 2: Modern approaches to nutritional research challenges: Targeted and non-targeted approaches for metabolite profiling in nutritional research.
    Lodge JK
    Proc Nutr Soc; 2010 Feb; 69(1):95-102. PubMed ID: 19954566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive Metabolomics Study To Assess Longitudinal Biochemical Changes and Potential Early Biomarkers in Nonobese Diabetic Mice That Progress to Diabetes.
    Buchwald P; Tamayo-Garcia A; Ramamoorthy S; Garcia-Contreras M; Mendez AJ; Ricordi C
    J Proteome Res; 2017 Oct; 16(10):3873-3890. PubMed ID: 28799767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
    Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
    Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolomics and its application in the treatment of coronary heart disease with traditional Chinese medicine.
    Wu GS; Li HK; Zhang WD
    Chin J Nat Med; 2019 May; 17(5):321-330. PubMed ID: 31171266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accelerated, untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice.
    Le Y; Shen X; Kang H; Wang Q; Li K; Zheng J; Yu Y
    J Mass Spectrom; 2018 Feb; 53(2):172-182. PubMed ID: 29160924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of metabolomics for unveiling the therapeutic role of traditional Chinese medicine in metabolic diseases.
    Wu G; Zhang W; Li H
    J Ethnopharmacol; 2019 Oct; 242():112057. PubMed ID: 31279867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.